Pharmaceuticals, Biotechnology and Life Sciences
– investors include Migdal and Phoenix Group – – New fund will invest in life sciences companies developing disruptive therapies…
Immunotherapy using LEAPS peptide technology may be able to reduce COVID-19 viral load and tissue damage resulting from infection in…
Center connects startups and academics to regulatory expertise; creates a forum for information sharing and networking WHIPPANY, N.J. & CAMBRIDGE,…
Planned HIMSS attendees can still learn about the AI toilet—slated for 2022 release—which gathers comprehensive health data in real-time PROVO,…
AVR-RD-04 is the third AVROBIO investigational gene therapy to receive orphan status CAMBRIDGE, Mass.–(BUSINESS WIRE)–$AVRO—AVROBIO, Inc. (Nasdaq: AVRO), a leading…
Phase 3 trial did not meet primary endpoint of progression-free survival in patients not eligible for transplant PRINCETON, N.J.–(BUSINESS WIRE)–$BMY—Bristol…
IRVING, Texas–(BUSINESS WIRE)–Vizient, Inc. announces it will participate in today’s Food and Drug Administration (FDA)/Federal Trade Commission (FTC) Workshop on…
– STRIDE 3 Met Both Prespecified Primary Efficacy Endpoints, Ocular Discomfort Severity in the Overall ITT Population and in ITT…
TURKU, Finland–(BUSINESS WIRE)–Medicortex Finland Oy announced today the start of a clinical trial for detection of mild Traumatic Brain Injury…
LONDON–(BUSINESS WIRE)–#GlobalPosttraumaticStressDisorderTherapeuticsMarket–The global post-traumatic stress disorder (PSTD) therapeutics market is poised to grow by USD 909.86 million during 2020-2024, progressing…